Prosecution Insights
Last updated: April 19, 2026

Immodulon Therapeutics Limited

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18252048 MYCOBACTERIAL IMMUNOTHERAPY FOR TREATING CANCER HAUK TEODORO, PRICILA NMN 1645 Non-Final OA May 08, 2023
17904155 PREVENTION AND TREATMENT OF INFECTIONS INCLUDING THOSE CAUSED BY CORONAVIRUS MORGAN, BAILEY MICHELLE 1645 Final Rejection Aug 12, 2022
17758139 IMMUNOTHERAPEUTIC TREATMENT OF CANCER ZEMAN, ROBERT A 1645 Final Rejection Jun 29, 2022

Managing Immodulon Therapeutics Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month